Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -18,299 | -66,944 |
| Depreciation Amortization | 730 | 3,079 |
| Accounts receivable | -4,474 | N/A |
| Accounts payable and accrued liabilities | 4,089 | N/A |
| Other Working Capital | -14,281 | 23,984 |
| Other Operating Activity | -797 | 8,968 |
| Operating Cash Flow | $-33,032 | $-30,913 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 628 | N/A |
| PPE Investments | -101 | -1,548 |
| Purchase Sale Intangibles | -76 | N/A |
| Other Investing Activity | -72 | -21,646 |
| Investing Cash Flow | $455 | $-23,194 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 55 | N/A |
| Other Financing Activity | -325 | 120,741 |
| Financing Cash Flow | $-270 | $120,741 |
| Exchange Rate Effect | 2,392 | -4,761 |
| Beginning Cash Position | 147,815 | 80,754 |
| End Cash Position | 117,361 | 142,627 |
| Net Cash Flow | $-30,454 | $61,872 |
| Free Cash Flow | ||
| Operating Cash Flow | -33,032 | -30,913 |
| Capital Expenditure | -101 | N/A |
| Free Cash Flow | -33,132 | -30,913 |